Reproducibility of sequential ambulatory blood pressure and pulse wave velocity measurements in normotensive and hypertensive individuals

por Keehn, Louise, Hall, Wendy L., Berry, Sarah E., Sanders, Thomas A.B., Chowienczyk, Phil, Floyd, Christopher N.
Publicado 2022

Novel Approach for Midface Attractiveness

por Yamamoto, Koji
Publicado 2022

An Algorithm for Prevention of Unsightly Facial Scars Considering the Newest Research Insights

por Feinendegen, Dominik L., Grubnik, Alexandra, Feinendegen, Sandra Y.
Publicado 2022

Does Fitzpatrick Score Predict Flap Loss? Microsurgical Breast Reconstruction Outcomes of Varying Skin Color

por Perez, Kevin, Steppe, Cyrus, Teotia, Sumeet S., Haddock, Nicholas T.
Publicado 2022

A Custom Stabilizing Splint for the Management of BLCP with Protruding Premaxilla

por Scott, Kaylee, Sudduth, Jack D., Ormiston, Laurel, Marquez, Jessica L., Jolly, Lisa, Zahid, Rehan, Siddiqi, Faizi, Yamashiro, Duane, Gociman, Barbu
Publicado 2022

T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Tri...

por Gallamini, Andrea, Picardi, Marco, Filonenko, Kateryna, Gotti, Manuel, Céspedes, Javier Núñez, Rossi, Andrea, Domingo-Domènech, Eva, Giza, Agnieszka, Sorasio, Roberto, Trentin, Livio, Oteiro, Mariana Bastos, Paszkiewicz-Kozik, Ewa, Sanz, Ramon García, Patti, Caterina, Chauvie, Stephane, Bergesio, Fabrizio, Guerra, Luca, Rambaldi, Alessandro, Balari, Ana Sureda, Zaucha, Jan Maciej
Publicado 2022

P030: Baseline IgM amount can identify patients with adverse outcome despite a PET-2 adapted treatment in classical Hodgkin Lymphoma: results from a real-life single-center study i

por Romano, Alessandra, Cerchione, Claudio, Santuccio, Gabriella, Le Moli, Marialudovica, Chiarenza, Annalisa, Figuera, Amalia, Motta, Giovanna, Caruso, L., Lanza, Sofia, Petronaci, A., Poidomani, S., Ippolito, Massimo, Di Raimondo, Francesco
Publicado 2022

P037: High breadth whole exome sequencing of circulating tumor DNA identifies novel recurrent genetic alterations in Hodgkin lymphoma

por Mammadova, Laman, Heger, Jan-Michel, Mattlener, Julia, Sobesky, Sophia, Cirillo, Melita, Bröckelmann, Paul J., Altmüller, Janine, Kirst, Elisabeth, Kreissl, Stefanie, Lohmann, Mia, Nürnberg, Peter, Engert, Andreas, Borchmann, Peter, Von Tresckow, Bastian, Borchmann, Sven
Publicado 2022

P067: A pilot of lung cancer screening for survivors of Hodgkin lymphoma

por Broadbent, Rachel, Crosbie, Philip, Radford, John, Armitage, Christopher J., Taylor, Ben, Mercer, Joseph, Tenant, Sean, Linton, Kim
Publicado 2022

P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival

por Baech, Joachim, Jakobsen, Lasse Hjort, El-Galaly, Tarec Christoffer, Molin, Daniel, Glimelius, Ingrid, Entrop, Joshua P., Crowther, Michael J., Smedby, Karin E., Eloranta, Sandra, Weibull, Caroline E.
Publicado 2022

P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment

por Mieras, Adinda, Nijdam, Annelies, Aleman, Berthe M. P., Daniels, Laurien, De Jongh, Eva, Janus, Cécile P.M., Krol, Stijn, Ta, Bastiaan D.P., Ong, Francisca, Van Spronsen, Dick Johan, Posthuma, Ward, Plattel, Wouter J., Oostvogels, Rimke, Verschueren, Karijn, Zijlstra, Josée. M., Van Leeuwen, Flora E.
Publicado 2022

P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma

por Kambhampati, Swetha, Mei, Matthew, Chen, Lu, Puvurel, Sandrine, Chen, Robert, Popplewell, Leslie, Nikolaenko, Liana, Peters, Lacolle, Armenian, Saro, Kwak, Larry, Rosen, Steven T., Forman, Stephen, Herrera, Alex F.
Publicado 2022

P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment

por Fedorova, Liudmila, Lepik, Kirill, Mikhailova, Natalia, Kondakova, Elena, Komarova, Yaroslava, Kotselyabina, Polina, Borzenkova, Evgenia, Baykov, Vadim, Moiseev, Ivan, Kulagin, Alexander
Publicado 2022

P042: Metabolic regulation of adaptive response to arginine deprivation in Hodgkin Lymphoma

por Romano, Alessandra, Scandura, Grazia, Santuccio, Gabriella, Puglisi, Fabrizio, Cambria, Daniela, Amorini, Angela Maria, La Spina, Enrico, Parrinello, Nunziatina Laura, Giallongo, Cesarina, Tibullo, Daniele, Cerchione, Claudio, Martinelli, Giovanni, Simonetti, Giorgia, Di Raimondo, Francesco
Publicado 2022

T066: Treatment and sex-specific exposure-based risk-stratification for care of survivors of childhood Hodgkin Lymphoma: A report from the Childhood Cancer Survivor Study

por Dinan, Michaela, Stratton, Kayla, Leisenring, Wendy, Yasui, Yutaka, Chow, Eric, Tonorezos, Emily, Moskowitz, Chaya, Yeh, Jennifer, Noyd, David, Armstrong, Gregory, Oeffinger, Kevin
Publicado 2022

P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Ind...

por Driessen, Julia, De Wit, Fer, Herrera, Alex F., Zinzani, Pier Luigi, Lacasce, Ann S., Cole, Peter D., Moskowitz, Craig H., Sanz, Ramón. García, Fuchs, Michael, Müller, Horst, Borchmann, Peter, Santoro, Armando, Schöder, Heiko, Zijlstra, Josée. M., Hutten, Barbara A., Moskowitz, Alison J., Kersten, Marie José
Publicado 2022

P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)

por Xagoraris, Ioanna, Stathopoulou, Konstantina, Renken, Stefanie, Lundqvist, Andreas, Claret, Francois Xavier, Drakos, Elias, Rassidakis, Georgios Z.
Publicado 2022

P068: A Retrospective Analysis of Fertility in Female Patients with Advanced Stages of Hodgkin Lymphoma Treated with BEACOPP Escalated Chemotherapy (25 Year Experience of a Single...

por Marková, Jana, Mociková, Heidi, Gaherová, Lubica, Klásková, Katerina, Maco, Maria, Dedeckova, Katerina, Kozak, Tomas
Publicado 2022

P086: Advancing Pediatric Hodgkin Lymphoma Research Through NODAL

por Flerlage, Jamie E., Birz, Suzi, Castellino, Sharon M., Appel, Burton, Furner, Brian, Graglia, Luca, Henderson, Tara O., Hodgson, David, Hoppe, Bradford S., Kahn, Justine, Keller, Frank G., Kessel, Sandy, Li, Chen, Li, Mei, Lucas, John, Mccarten, Kathleen, Metzger, Monika, Milgrom, Sarah, Parsons, Susan K., Pei, Qinglin, Wu, Yue, Zhou, Yiwang, Watkins, Michael, Volchenbaum, Sam, Kelly, Kara M.
Publicado 2022

T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients

por Övergaard, Ninja, Lia, Kjersti, Asdahl, Peter, Wikman, Per, Glimelius, Ingrid, Lagerlöf., Ingemar, Johansson, Ann-Sofie, Hansson, Lotta, Enblad, Gunilla, Linderoth, Johan, Goldkuhl, Christina, Fosså, Alexander, Kamper, Peter, Molin, Daniel
Publicado 2022